Partnership to Accelerate Clinical Trials (PACT)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2014
  • Initiating Organization: Bay Area BioEconomy Initiative
  • Initiator Type: Academia
  • No disease focus
  • Location: North America


The Partnership to Accelerate Clinical Trials (PACT) consists of 11 California health systems and medical research institutions, including five University of California (UC) campuses, Stanford University, Children's Hospital Oakland, Dignity Health, and Sutter Health.


PACT originated through Clay Johnston, UC San Francisco (SF) associate vice chancellor of research, as a Bay Area-centric effort to help drug developers launch and manage multiple clinical trial sites. PACT will manage a centralized institutional review board (IRB), assuring that each trial site's standards are met.

PACT aims to halve the typical multi-month startup process of initiating clinical trials—time that contributes substantially to cost, ultimately impeding progress in developing new treatment options for patients.

Once implemented in California, Bay Area BioEconomy Initiative and PACT plan to grow the network across the U.S., with the goal of creating a national model to accelerate and increase the quality of clinical trials.

Consortium History

January 2014: PACT announced


Support for the development of PACT is provided by UCSF’s Clinical and Translational Science Institute, which is funded by the National Center for Advancing Translational Sciences at the National Institutes of Health (Grant Number UL1 TR000004).

Sponsors & Partners

Children’s Hospital Oakland

Dignity Health

Stanford University

Sutter Health

University of California, Davis

University of California, San Francisco

Last Updated: 04/08/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.